Literature DB >> 993125

Enhancement of delayed-type hypersensitivity by bestatin, an inhibitor of aminopeptidase B and leucine aminopeptidase.

H Umezawa, M Ishizuka, T Aoyagi, T Takeuchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 993125     DOI： 10.7164/antibiotics.29.857

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  11 in total

1.  Pharmacokinetics of bestatin and oral activity for treatment of experimental metastases.

Authors:  F Abe; G Alvord; M Koyama; A Matsuda; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Prospective randomized controlled study on bestatin in resectable gastric cancer--third report.

Authors:  M Niimoto; T Saeki; M Toi; M Nishiyama; T Hirai; E Yanagawa; T Hattori
Journal:  Jpn J Surg       Date:  1990-03

3.  Captopril(SQ 14,225): in vitro and in vivo influence on the proliferative response of rat lymphocytes.

Authors:  L Binderup; E Bramm; E Arrigoni-Martelli
Journal:  Experientia       Date:  1982-03-15

4.  Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder. Clinical results of a randomized trial.

Authors:  H Blomgren; I Näslund; P L Esposti; L Johansen; O Aaskoven
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

5.  Effects of bestatin on myelopoietic stem cells in normal and cyclophosphamide-treated mice.

Authors:  F Abe; A Matsuda; M Schneider; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

6.  Stimulation of cell-mediated immunity by bestatin correlates with reduction of bacterial persistence in experimental chronic Salmonella typhimurium infection.

Authors:  G Dickneite; F Kaspereit; H H Sedlacek
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

7.  Restoration of impaired immune functions of aged animals by chronic bestatin treatment.

Authors:  M Bruley-Rosset; I Florentin; N Kiger; J Schulz; G Mathé
Journal:  Immunology       Date:  1979-09       Impact factor: 7.397

8.  Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in mice.

Authors:  F Abe; M Schneider; P L Black; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

9.  Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease.

Authors:  P A Paganetti; P Caroni; M E Schwab
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

10.  Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme.

Authors:  S Tieku; N M Hooper
Journal:  Biochem Pharmacol       Date:  1992-11-03       Impact factor: 5.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.